¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Fast excitatory postsynaptic potentials"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • postsynaptic terminal
    ½Ã³À½ºÀÌÈÄÁ¾¸», ¿¬Á¢ÀÌÈÄÁ¾¸»
  • subliminal excitatory process
    ¹®ÅιØÈïºÐ°úÁ¤
  • acid-fast
    Ç×»ê-
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast organism
    Ç×»ê±Õ
  • acid-fast stain
    Ç׻꿰»ö
  • drug-fast
    ¾à¹°³»¼º-
  • fast channel
    ±Þ¼ÓÅë·Î
  • fast gradient recalled echo method
    °í¼Ó±â¿ï±âȸº¹¿¡ÄÚ¹ý
  • fast hemoglobin
    ±Þ¼ÓÇ÷»ö¼Ò
  • fast imaging technique
    °í¼Ó¿µ»ó±â¹ý
  • fast spin echo
    °í¼Ó½ºÇÉ¿¡ÄÚ
  • fast time constant circuit
    °í¼Ó½Ã°£°íÁ¤È¸·Î
  • fast twitch fiber
    ºü¸¥¿¬Ãà±Ù(À°)¼¶À¯
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • postsynaptic terminal
    ¿¬Á¢ÈÄÁ¾¸»
  • subliminal excitatory process
    ¿ªÇÏÈïºÐ°úÁ¤
  • arsenic-fast
    ºñ¼Ò°ßµõ¼º-, Ç׺ñ¼ÒÁßµ¶-
  • acid fast organism
    Ç×»ê±Õ
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast stain
    Ç׻꿰»ö
  • fast channel
    ±Þ¼ÓÅë·Î
  • fast time constant circuit
    °í¼Ó½Ã°£°íÁ¤È¸·Î
  • drug-fast
    ¾àÁ¦³»¼º-
  • fast scan effect
    °í¼Ó½ºÄµÈ¿°ú
  • fast spin echo
    °í¼Ó½ºÇÉ¿¡ÄÚ
  • fast hemoglobin
    ±Þ¼ÓÇ÷»ö¼Ò
  • fast scan
    °í¼Ó½ºÄµ
  • fast gradient recalled echo method
    °í¼Ó±â¿ï±âȸº¹¿¡ÄÚ¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acid-fast bacillus
    Ç×»ê±Õ(ù÷߫ж)
  • acid-fast stain
    Ç׻꼺 ¿°»ö
  • acid-fast stain
    Ç׻꼺¿°»ö(ù÷ß«àõæøßä)
  • IPSP = inhibitory postsynaptic potential
    ¾ïÁ¦¼º(åäð¤àõ)½Ã³À½ºÈÄ(ý­)Àü¾Ð(ï³äâ)
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄ Àü¾Ð
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory postsynaptic potential = IPSP
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • postsynaptic
    ½Ã³³½ºÈÄ(ºÎ)(¡­ý­Ý»)ÀÇ, Á¢ÇÕºÎÈĺÎ(ïÈùêÝ»ý­Ý»)ÀÇ.
  • postsynaptic
    ½Ã³³½ºÈÄ(ºÎ)(¡­ý­Ý»)ÀÇ, Á¢ÇÕºÎÈĺÎ(ïÈùê
  • postsynaptic density
    ¿¬Á¢ÀÌÈÄÄ¡¹ÐÁú
  • postsynaptic inhibition
    ½Ã³³½ºÈľïÁ¦ (¡­ý­åäð¤).
  • postsynaptic inhibition
    ¿¬Á¢ÈľïÁ¦
  • postsynaptic membrane
    ¿¬Á¢ÀÌÈĸ·, ½Ã³³½ºÈĸ·(¡­Ø¯).
  • postsynaptic membrane
    ¿¬Á¢ÀÌÈĸ·
  • postsynaptic neuron
    ½Ã³³½ºÈÄ´º·Ð.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄ Àü¾Ð
  • inhibitory postsynaptic potential = IPSP
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • postsynaptic
    ½Ã³³½ºÈÄ(ºÎ)(¡­ý­Ý»)ÀÇ, Á¢ÇÕºÎÈĺÎ(ïÈùêÝ»ý­Ý»)ÀÇ.
  • postsynaptic
    ½Ã³³½ºÈÄ(ºÎ)(¡­ý­Ý»)ÀÇ, Á¢ÇÕºÎÈĺÎ(ïÈùê
  • postsynaptic density
    ¿¬Á¢ÀÌÈÄÄ¡¹ÐÁú
  • postsynaptic inhibition
    ½Ã³³½ºÈľïÁ¦ (¡­ý­åäð¤).
  • postsynaptic inhibition
    ¿¬Á¢ÈľïÁ¦
  • postsynaptic membrane
    ¿¬Á¢ÀÌÈĸ·, ½Ã³³½ºÈĸ·(¡­Ø¯).
  • postsynaptic membrane
    ¿¬Á¢ÀÌÈĸ·
  • postsynaptic neuron
    ½Ã³³½ºÈÄ´º·Ð.
  • postsynaptic part
    ¿¬Á¢ÀÌÈĺκÐ
  • postsynaptic potential
    ½Ã³³½ºÈÄÀü¾Ð.
  • postsynaptic receptor
    ¿¬Á¢Èļö¿ëü
  • postsynaptic web
    ¿¬Á¢ÀÌÈÄÁý, ½Ã³³½ºÈÄÁý.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fast spin echo imaging
    °í¼Ó½ºÇÉ¿¡ÄÚ¿µ»ó
  • fast time constant circuit
    °í¼Ó½Ã°£°íÁ¤È¸·Î
  • FAST(Fourier acquisition in the steady state) sequence
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ¿¬¼â
  • FFE [=fast field echo]
    ±Þ¼ÓÀÚÀå¿¡ÄÚ
  • Fourier acquisition in the steady state [=FAST]
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ
  • ultra fast sequence
    Ãʰí¼Ó¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IPSC inhibitory postsynaptic current
IPSP inhibitory postsynaptic potential
PSD particle size distribution; peptone, starch, and dextrose; periodic synchronous discharge; phase-sen...
PSP pancreatic spasmolytic peptide; paralytic shellfish poisoning; parathyroid secretory protein; period...
EPSP Excitatory Post-Synaptic Potential; ÈïºÐ¼º ½Ã³À½ºÈÄ ÀüÀ§
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MEPSP Miniature excitatory postsynaptic potential
mEPSCs Miniature excitatory postsynaptic currents
pEPSP population excitatory postsynaptic potential
sEPSCs Spontaneous excitatory postsynaptic currents
IPSPs inhibitor postsynaptic potentials
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fast fiber
    ¼Ó¼¶À¯
  • fast Fourier imaging
    °í¼Ó Fourier ¿µ»ó
  • fast gradient recalled echo method
    °í¼Ó °æ»ç ȸº¹ ¿¡ÄÚ ±â¹ý
  • fast imaging with steady state precession
    Ç×Á¤ »óÅ ¼¼Â÷ ¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó ¿µ»ó
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó ´Ù¸é ȸ¼Õ °æ»ç ȸº¹ ¿¬¼â
  • fast scan
    °í¼Ó ½ºÄµ
  • fast scan imaging
    °í¼Ó ½ºÄµ ¿µ»ó
  • fast spin echo
    °í¼Ó ½ºÇÉ ¿¡ÄÚ
  • fast time constant circuit
    °í¼Ó ½Ã°£ °íÁ¤ ȸ·Î
  • fast-twitch fiber muscle
    ½Å¼Ó ¿¬Ãà±Ù ¼¶À¯
  • sero-fast
    Ç÷û ³»¼ºÀÇ
    µ¿ÀǾî=serum-fast.
  • serum-fast
    Ç÷û ³»¼ºÀÇ. Ç÷û ÀúÇ×¼ºÀÇ
    Ç÷ûÀÇ ÆÄ±« È¿°ú¿¡ ÀúÇ×¼ºÀÌ ÀÖ´Â ¼¼±Õ¿¡ ´ëÇØ¼­ ¸»ÇÑ´Ù.
  • Wasserman fast
    ¹Ù¼¼¸£¸¸ ¹ÝÀÀ ÀúÇ×¼ºÀÇ
    ¸Åµ¶ Ä¡·á¸¦ ¹ÞÀº ȯÀÚ¿¡°Ô ¹Ù¼¼¸£¸¸ ¹ÝÀÀÀÌ Áö¼ÓÀûÀ¸·Î ¾ç¼ºÀ¸·Î ³ªÅ¸³ª´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
evoked potentials, auditory, brainstem Electrical waves in the cerebral cortex generated by brainstem structures in response to auditory click stimuli. These are found to be abnormal in many patients with cerebellopontine angle lesions, multiple sclerosis, or other demyelinating diseases.
(12 Dec 1998)
evoked potentials, motor The electrical response evoked in a muscle or motor nerve by electrical or magnetic stimulation. Common methods of stimulation are by transcranial electrical and transcranial magnetic stimulation. It is often used for monitoring during neurosurgery.
(12 Dec 1998)
evoked potentials, somatosensory The electric response evoked in the cerebral cortex by stimulation of afferent pathways from peripheral nerves to cerebrum.
(12 Dec 1998)
evoked potentials, visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways.
(12 Dec 1998)
excitatory Tending to produce excitation.
(05 Mar 2000)
excitatory amino acid <biochemistry> The naturally occurring amino acids L glutamate and L aspartate and their synthetic analogues, notably kainate, quisqualate and NMDA. They have the properties of excitatory neurotransmitters in the CNS, may be involved in long-term potentiation and can act as excitotoxins.
at least three classes of EAA receptor have been identified, the agonists of the N type receptor are L aspartate, NMDA and ibotenate, the agonists of the Q type receptor are L glutamate and quisqualate, agonists of the K type are L glutamate and kainate. All three receptor types are found widely in the CNS and particularly the telencephalon, N and Q type receptors tend to occur together and may interact, their distribution is complementary to the K type receptors. The ion fluxes through the Q and K receptors are relatively brief, whereas the flux through the N type is longer and carries a significant amount of calcium. Additionally the N type receptor is blockaded by magnesium near the resting potential and thus shows voltage gated ion channel properties, leading to a regenerative response, this is why N type receptors have been linked to long-term potentiation.
Invertebrate glutamate receptors may not have the same properties as those described above.
(18 Nov 1997)
excitatory amino acid agents Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.
(12 Dec 1998)
excitatory amino acid agonists Drugs that bind to and activate excitatory amino acid receptors.
(12 Dec 1998)
excitatory amino acid antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
(12 Dec 1998)
excitatory amino acids Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear.
(12 Dec 1998)
excitatory junction potential Discrete partial depolarisation of smooth muscle produced by stimulation of excitatory nerves; similar to small end-plate potentials. They summate with repeated stimuli.
(05 Mar 2000)
excitatory synapse <physiology> A synapse (either chemical or electrical) in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell.
See: inhibitory synapse.
(18 Nov 1997)
local excitatory state Increased irritability of a nerve fibre or muscle fibre which is produced by an ineffective electrical stimulus; summation of the stimuli may occur, resulting in a propagated impulse if two or more subliminal stimuli are applied in rapid succession.
(05 Mar 2000)
acid-fast <microbiology> A term used to denote bacteria that are not decolorised by acid-alcohol after having been stained with dyes such as basic fuchsin.
The presence of acid fast organisms can be found in cultures that contain mycobacteria or some of the nocardiae.
(12 Jul 2000)
acid-fast stain <technique> A staining technique used to determine the cell wall property of a microorganism. After stained with dye such as hot carbolfuschin, an acid-fast organism, (for example Mycobacterium species) will retain the colour in its cell wall after being washed with acid-alcohol.
(13 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á